Aller au contenu principal
Profil bibliographique

Zainub Ajmal

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

24Publications signalées
63Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer Immunotherapy and BiomarkersSarcoma Diagnosis and TreatmentVirus-based gene therapy researchBRCA gene mutations in cancerTransplantation: Methods and Outcomes

Les publications récentes

Accès ouvert 2025 conference-abstract OpenAlex

A phase I trial of intratumoral adenovirus-interleukin-12 (IT-ADV/IL-12) and atezolizumab in metastatic non-small cell lung cancer (NSCLC) progressed on first-line immunotherapy.

Zainub Ajmal, Jian Guan, Jitesh Joshi, Eric Bernicker et autres

8551 Background: Interleukin-12 (IL-12) is a cytokine that enhances anti-tumor immunity via interferon-gamma release and has demonstrated synergistic effects with immune checkpoint inhibitors (ICIs) in immunoquiescent tumors. We report results of phase I trial of intratumoral adenovirus-interleukin-12(IT-ADV/IL-12)plus atezolizumab in metastatic NSCLC patients …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology
Accès ouvert 2024 preprint OpenAlex

Exploring Large Language Models for Specialist-level Oncology Care

Anil Palepu, Vikram Dhillon, Polly Niravath, Wei‐Hung Weng et autres

Large language models (LLMs) have shown remarkable progress in encoding clinical knowledge and responding to complex medical queries with appropriate clinical reasoning. However, their applicability in subspecialist or complex medical settings remains underexplored. In this work, we probe the performance of AMIE, …

0 citations arXiv (Cornell University)
2024 conference-abstract OpenAlex

Outcomes of liver transplant recipients with pretransplant malignancies: Insights from a single institution’s experience.

Nikitha Vobugari, Kirk Heyne, Ashton A. Connor, Zainub Ajmal et autres

11173 Background: Increasing liver transplantation (LT) utilization has resulted in more and more patients with a history of a non-hepatobiliary malignancy. Rather than deny such patients a lifesaving therapy the benefits must be weighed against risk of tumor recurrence and de novo …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2024 conference-abstract OpenAlex

5-hydroxymethylcytosine in cell-free DNA as liquid biomarker for immune checkpoint inhibitor therapy in non–small cell lung cancer.

Zainub Ajmal, Jianming Shao, Randall J. Olsen, Saro Kasparian et autres

e20563 Background: Immune checkpoint inhibitors (ICIs) targeting programmed cell death 1 (PD-1), and its ligand (PD-L1) are the mainstay of treatment for metastatic non-small cell lung cancer (NSCLC) in patients lacking targetable driver mutations. However, optimal predictive biomarkers are lacking. We used …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2024 conference-abstract OpenAlex

Real-world experience on tolerability and safety of relugolix combined with androgen signaling inhibitors in patients with advanced prostate cancer.

Jian Guan, Shubham Adroja, Zainub Ajmal, Yuan Gao et autres

85 Background: Relugolix is the first oral GNRH antagonist approved by the FDA in 2021 for the treatment of advanced prostate cancer (PCa). Approval was based on HERO study, which showed a rapid and sustained testosterone suppression superior to that of Leuprolide …

us (code pays fourni par la source)

5 citations Journal of Clinical Oncology
Accès ouvert 2023 conference-abstract OpenAlex

Clinical outcomes of patients with early-stage epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer who underwent reflex molecular testing.

Ryan Blair Kieser, Ethan Burns, Zimu Gong, Jian Guan et autres

e20531 Background: One-third of patients with newly diagnosed non-small cell lung cancer (NSCLC) present at an early stage. Surgical resection remains the standard of care for medically fit patients. Adjuvant chemotherapy has shown benefit in stage II and III disease, but with …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2022 article OpenAlex

Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger

Amin Azem, Zainub Ajmal, Mihir Raval

Allogeneic hematopoietic stem cell transplant (AHSCT) recipients are at a risk of developing immune-mediated tissue damage from activation of the donor's immunocompetent T cells by the recipient's normally expressed antigens, a phenomenon called graft-versus-host disease (GVHD). With the emergence of the novel …

us (code pays fourni par la source)

1 citation Cureus
Accès ouvert 2022 article OpenAlex

Leiomyosarcoma of the Penis: A Case Report and Re-Appraisal

Zainub Ajmal

Background: Penile leiomyosarcoma arises from smooth muscles, which can be from dartos fascia, erector pili in the skin covering the shaft, or from tunica media of the superficial vessels and cavernosa. We describe presentation, treatment options, and recurrence pattern of this rare …

us (code pays fourni par la source)

4 citations Federal Practitioner

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.